Takeda, a Japanese pharmaceutical company, plans to launch its dengue vaccine, Qdenga, in India next year in collaboration ...

Jonathan Rockoff is the Health Business editor at The Wall Street Journal, managing a team that reports on pharmaceutical and biotechnology companies, health insurers and hospitals. During the ...

The EMA’s Committee for Medicinal Products for Human Use adopted a positive opinion, recommending a change to the terms of the marketing ...

The Irish arm of pharma firm, Takeda, last year sustained a €37.2m hit to profits after mothballing new manufacturing ...

Recursion Pharmaceuticals, Inc.’s RXRX share price has surged by 7.02%, which has investors questioning if this is right time ...

Takeda Pharmaceuticals, Japan's largest drugmaker, has undergone a sweeping transformation under CEO Christophe Weber, ...